Histolix provides an intrinsically digital and slide-free histopathology solution.
Histolix has raised $3.2M in total funding. The most recent round was Grant. The last funding was announced in June 2023.
Histolix's investors include National Cancer Institute.
Histolix is headquartered in Sacramento, United States.
Histolix provides an intrinsically digital and slide-free histopathology solution.
Histolix is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Histolix — Funding & Investors." VCBacked, June 28, 2023, https://www.vcbacked.co/company/histolix. Accessed August 13, 2026.
VCBacked. (2023). Histolix — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/histolix
{{cite web |title=Histolix — Funding & Investors |url=https://www.vcbacked.co/company/histolix |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated